Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has initiated a Phase 1 clinical study of NMRA-898, a M4 Positive Allosteric Modulator.
Senator Questions 946 Infra Projects SENATE Finance Committee Chair Senator Sherwin T. Gatchalian said about 946 projects worth P14.4 bill…
Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc. announced the presentation of new preclinical data …
Prairie Portraits: Alex Rapp The Prairie Portraits series features founders, funders and community builders from Nebraska's innovation and…
ASX Market Update The Australian stock market is experiencing a decline, led by significant losses in the healthcare and tech sectors, des…
Leatt Releases New Outerwear and Glasses for 2026 Leatt has introduced its new 2026 range of outerwear and sunglasses in its 2026 mountain…
Potential Human Pandemic from Bird Flu Strain A bird flu virus, H9N2, has the potential to spark a human pandemic, according to a team of …
Designing Light-Filled Living Spaces: How Lifestyle Remodeling Is Shaping the Future of Tampa Sunrooms In Florida, natural light is one of…
Lululemon to Sell NFL Apparel in Fanatics Deal Lululemon has entered an arrangement with the NFL and Fanatics to develop a line of fan app…
Introduction to Circuit Design with Capacitors Among the abundance of components making up electronic circuits, very few are as important …
A Studio With a Heated Solarium on West 14th for $780,000 For under a million dollars, various housing configurations are available, inclu…